ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01359969
Recruitment Status : Recruiting
First Posted : May 25, 2011
Last Update Posted : October 17, 2016
Sponsor:
Information provided by (Responsible Party):
Pharming Technologies B.V.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : December 2017

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 3, 2018
May 3, 2018